drugset / Trial / NCT06550609

Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine

NCT06550609

Phase 2 Recruiting 30 enrolled Fundacion Nacional de Dermatologia
NaSingle-groupOpen-labelTreatment

Summary

This is a phase 2 study of the combination of inhaled-pentamidine plus oral miltefosine for Bolivian mucosal leishmaniasis.

Timeline

Start
2025-02-04
Primary completion
2027-11
Completion
2028-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Miltefosine Small molecule Oral
Subject Pentamidine Unknown 300 mg Inhaled